Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 16/07/2012 17688_de.jpg

    Winners of the "Science2Start" ideas competition honoured

    BioRegio STERN Management GmbH honoured the three winners of the regional "Science2Start" ideas competition last Thursday evening. The award ceremony was part of the traditional summer soirée given by BioRegio STERN Management GmbH in collaboration with TTR Technologieparks Tübingen-Reutlingen GmbH, the Verein zur Förderung der Biotechnologie und der Medizintechnik e.V. (Society for the Promotion of Biotechnology and Medical Technology)…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/winners-of-the-science2start-ideas-competition-honoured
  • Article - 05/02/2008 Portrait of Dr. Martin Schneider

    Protecting the liver from oxygen stress

    The Emmy Noether junior research group in the Department of Surgery at the University Hospital of Heidelberg is to be funded with 1.2 million over the next five years. The group will focus on how tissue damage in donor livers can be prevented. The group headed by Dr. Martin Schneider.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/protecting-the-liver-from-oxygen-stress
  • Press release - 27/11/2010

    New metabolic model provides insights into Alzheimer’s disease

    The combination of a newly developed bioinformatic model and experimental data provides new insights into the causes of Alzheimers disease. Researchers found that whilst the activity of a particular enzyme is reduced specific nerve cells are able to counteract this deficiency by rerouting the metabolic fluxes.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/new-metabolic-model-provides-insights-into-alzheimer-s-disease
  • Article - 17/02/2009 08087_de.jpg

    Tissue engineering companies and EU obstacles

    With the new regulation on advanced therapy medicinal products the European Union has tried to establish legal certainty with regard to gene therapy somatic cell therapy and tissue engineering products. However Dr. Heinz W. Joseph of TETEC AG is sure that the new guidelines will lead to problems for small and medium-sized companies.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/tissue-engineering-companies-and-eu-obstacles
  • Article - 04/10/2010 The figure shows two RNA molecules that interact with each other through loop structures.<br /> <br />

    Computer models for underestimated all-rounders

    It has now become clear that non-coding RNAs are the puppeteers in cells. Prof. Dr. Rolf Backofens team at the University of Freiburg is developing an indispensable tool for doing just this in the form of computer programmes that generate two-dimensional structural models of these tiny all-rounders.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/computer-models-for-underestimated-all-rounders
  • Press release - 27/01/2009 Patrick Dieckhoff (transkript), Kai-Uwe Bindseil (BioTop), Peter Heinrich (chairman of the board of BIO Deutschland) and Viola Bronsema (managing director of BIO Deutschland) presented the results of the survey.

    Survey results show the biotech sector is cautiously optimistic

    Despite the current financial crisis more than 90 of German biotech companies consider their current situation to be good 48 or satisfactory 43. So say the results of a survey carried out by the German Biotechnology Industry Organisation BIO Deutschland and the life sciences journal transkript.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/survey-results-show-the-biotech-sector-is-cautiously-optimistic
  • Article - 07/01/2016 Schematic showing a B-cell receptor in the plasma membrane and the protein Kidins220.

    New protein helps B cells generate an effective immune response

    The human immune system plays a key role for human health. Dr. Gina Fiala, a scientist in Prof. Dr. Wolfgang Schamel’s team in the Department of Immunology at Freiburg University, has discovered Kidins220/ARMS in B cells. Kidins220/ARMS is part of the adaptive immune system where it plays a key role in the maturation of B cells.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/kidins220-hilft-b-zellen-bei-der-immunabwehr
  • Article - 19/04/2017 View of a laboratory work place with a broad range of laboratory utensils in which a person (on the left, wearing a white lab coat) is working with frozen samples.

    Are start-ups a matter for the boss? A professor’s thoughts on university spin-offs

    Research work and entrepreneurship are by no means mutually exclusive. There are numerous successful university spin-offs in the life sciences sector that prove this only too well. However, the road from a good idea to a commercially successful company can be long and arduous. Those who benefit from the support of their boss from the outset can consider themselves extremely fortunate. Prof. Dr. Hans-Georg Rammensee talks about his experience with…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/are-start-ups-a-matter-for-the-boss-a-professors-thoughts-on-university-spin-offs
  • Dossier - 13/05/2013 19501_de.jpg

    The human proteome – the next major goal

    The “Human Proteome Project”, a ten-year global initiative that is making a systematic effort to map all human proteins, has moved from the planning to the experimental stage. How significant and how effective the project will be depends on how much the resources offered are used by proteome researchers and on the data that the researchers bring into the project.

    https:////www.gesundheitsindustrie-bw.de/en/article/dossier/the-human-proteome-the-next-major-goal
  • Article - 03/12/2008

    Esslingen scientists to recalculate human age

    The actual age of a person not only depends on the date he or she was born. Biological age, which is far more important in determining lifespan, can so far only be estimated rather than precisely calculated. The European MARK-AGE research project is working on finding a solution to this problem. Esslingen plays a major role in this project for two reasons: the structure of the city and the company BioTeSys.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/esslingen-scientists-to-recalculate-human-age
  • Article - 31/03/2014 21168_de.jpg

    The growing significance of peptide therapeutics

    The therapeutic use of peptides lags behind that of proteins. And there are good reasons for this. However, it seems that this is beginning to change and that peptide therapeutics are growing in significance. As a matter of fact, peptides have become rather popular candidates for drugs.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/the-growing-significance-of-peptide-therapeutics
  • Press release - 15/09/2020

    ELLIS inaugurates 30 research units at leading institutions across Europe

    At a virtual event on Tuesday, the European Laboratory for Learning and Intelligent Systems presented the broad scope of research its units will cover in the field of modern AI.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/ellis-offizieller-start-der-30-forschungseinheiten-fuehrenden-institutionen-ganz-europa
  • Article - 29/04/2010 VFA_4C.jpg

    The biopharmaceutical industry remained stable in times of crisis

    The German biopharmaceutical industry has come through 2009 without experiencing too many major slumps. The roaring growth of the biopharmaceutical industry in previous years has been replaced by more moderate growth. This is the result published by the 4th Medical Biotechnology report in 2010 compiled on behalf of the biotech interest group of the vfa bio Association of Research-Oriented Pharmaceutical Companies by the Boston Consulting Group.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/the-biopharmaceutical-industry-remained-stable-in-times-of-crisis
  • Article - 07/06/2017 The fruit fly Drosophila is used as obesity model. The fat tissue has been visualised by way of GFP (green fluorescent protein) expression.

    A gene that regulates body heat and fat storage

    Researchers from Heidelberg have shown that the organismal balance between heat production and energy storage is regulated by a gene called THADA. In animal experiments, knocking out the THADA gene leads to excessive food intake, obesity and sensitivity to cold. As humans spread throughout the world and settled in different climate zones, THADA was exposed to high selection pressure due to evolutionary adaptation. This explains why human…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/a-gene-that-regulates-body-heat-and-fat-storage
  • Article - 04/07/2017 The photo shows Prof. Dr. Nikolas von Bubnoff and Prof. Dr. Robert Zeiser at the award ceremony.

    Ruxolitinib – successful graft-versus-host disease treatment

    Graft-versus-host disease is a serious complication in leukaemia patients who have been given a blood stem cell transplant from a genetically different person. Prof. Dr. Nikolas von Bubnoff and Prof. Dr. Robert Zeiser from the Department of Haematology, Oncology and Stem Cell Transplantation at Freiburg University Medical Centre initiated a Germany-wide study to show that an active substance called ruxolitinib has a promising therapeutic effect.…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/ruxolitinib-successful-graft-versus-host-disease-treatment
  • Article - 14/07/2014 The photo shows Andreas Marx and Martin Scheffner in the laboratory and evaluating a Petri dish.

    Andreas Marx – “Chemical Biology” of DNA polymerases

    Whether inside the cell or in molecular biology laboratories, the synthesis of DNA would not be possible without DNA polymerases. The regulation and application of this versatile enzyme family is the subject of research carried out by Prof. Dr. Andreas Marx at the University of Konstanz in Southern Germany. In addition to basic research into naturally occurring DNA polymerases, Marx deals with the development of novel polymerases that can be used…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/andreas-marx-chemical-biology-of-dna-polymerases
  • Article - 30/03/2009 08262_de.jpg

    Innovative sunscreen for noninvasive therapies

    The importance of sunlight for human health becomes particularly obvious when people do not receive sufficient sunlight. A prime example of this is rachitis also known as English disease which is caused by vitamin D deficiency. However the exposure to too much sunlight can also be dangerous. The Empfingen-based company HelioVital has now developed a special film that enables the therapeutic use of the positive effects of sunlight without causing…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/innovative-sunscreen-for-noninvasive-therapies
  • Article - 08/12/2014 Portrait of Stefan Hell

    Stefan Hell – a Nobel Prize for a lateral thinker

    Stefan Hell was awarded the Nobel Prize in Chemistry for the development of STED fluorescence microscopy which has made it possible to obtain optical images well below the optical diffraction limit. However, Hell does not really see himself as a developer. His passion is scientific principles, the identification of how things are connected and the exploration of new, uncharted paths.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/stefan-hell-a-nobel-prize-for-a-lateral-thinker
  • Article - 10/06/2008

    Heiko Möller - Uncovering molecular structures

    Professor Heiko Möller teaches chemistry at the University of Constance and is a specialist in nuclear magnetic resonance spectroscopy. He enjoys working with other people including colleagues from the field of chemistry and also biologists and tropical disease specialists. Möller returned from the USA to accept a junior professor position at Constance University.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/heiko-moeller-uncovering-molecular-structures
  • Article - 14/07/2009 Dr. Marcus Groettrup holding a test tube and pipette.

    Tiny particles are a weapon against tumours

    Prostate carcinoma is one of the most common malignant diseases claiming more than 84000 lives per year in the EU and the United States. In cooperation with the University of Constance the Thurgau Biotechnology Institute BITg is working on ways to remove prostate carcinomas and other tumours that are difficult to treat by using tiny particles made of biologically degradable polyester. Prof. Dr. Marcus Groettrup and his team of researchers have…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/tiny-particles-are-a-weapon-against-tumours
  • Article - 11/07/2010 The photo shows the face of a man.

    Complex issues relating to membranes

    Dr. Uwe Schulte of the Freiburg-based biotech company Logopharm GmbH is a specialist in the analysis of membrane proteins membrane protein complexes and functional networks involving membrane proteins. In an interview with BIOPRO Schulte expresses his views on the direction research should take.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/complex-issues-relating-to-membranes
  • Article - 11/02/2013 19172_de.jpg

    REGiNA – the health region for regenerative medicine

    REGiNA is a users’ centre for regenerative medicine in the area bordered by the cities of Stuttgart and Tübingen and the Neckar-Alb region. It was established with the aim of translating a variety of advanced regenerative methods into broad clinical application. Providing a diverse and broad range of information, REGiNA is focused on making new treatment possibilities and the opportunities created by regenerative medicine known to doctors,…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/regina-the-health-region-for-regenerative-medicine
  • Article - 12/07/2010 The photo illustrates the relationship between sugar and diabetes by showing a sugar-covered area with an omission in the shape of a person.

    Twelve in one fell swoop – New type 2 diabetes genes

    An international team of scientists working on the largest diabetes study to date have found 12 new diabetes genes in around 140000 Europeans. One of the authors the endocrinologist Bernhard Böhm from Ulm considers the findings to be a breakthrough in the research and treatment of type 2 diabetes.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/twelve-in-one-fell-swoop-new-type-2-diabetes-genes
  • Press release - 05/09/2017 PET-Gerat-Uni-Tubingen.jpg

    Cell marking opens up a window into the body

    A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer's and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life…

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cell-marking-opens-up-a-window-into-the-body
  • Press release - 03/08/2009 Probe station for nanotransport analyses. The photo shows a researcher looking through a microscope.

    An investment in the future is being made at the University of Constance

    A few weeks ago the Max Planck Society approved the establishment of a new International Max Planck Research School IMPRS for Organismal Biology at the Excellence University of Constance. The International Research School will be established in order to investigate the complex interactions between the organism and environment as well as between organisms.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/an-investment-in-the-future-is-being-made-at-the-university-of-constance

Page 26 / 29

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • sb_theme_biopro.domain.mdr-ivdr
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search